CVS big bet on primary care hasn’t yet come to pass, Barron’s says

Late last year, CVS Health CEO Karen Lynch unveiled a new strategy: Rather than remain simply a pit stop for toilet paper and flu shots, CVS stores would become a place that Americans-particularly older ones-go to see their doctor. A year later, the company has yet to execute on this vision, Josh Nathan-Kazis writes in this week’s edition of Barron’s. The stock price suggests that investors are skeptical, even if the Street generally approves of Lynch’s grand plans, the author adds. That uncertainty is warranted, and investors attached to an aggressive timeline for the company’s transformation may not find much to celebrate in the short term. But for those with a buy-and-hold approach, it’s worth delving into what roadblocks the company now faces and how likely it is to clear them, the publication adds. Reference Link